Clinical Trial Update: A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 study completed evaluating the safety and tolerability of NDX-3315 and NDX-3324 in healthy participants and patients with eosinophilic esophagitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• NDX-3315
• NDX-3324

Snippet

Sponsor: NexEos Diagnostics, Inc. | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED